White label ELPA - ClinicalTrials.eu

A study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.

Not recruiting

3 1 1 1
Investigated Diseases:
- Diffuse large B-cell lymphoma refractory
Investigated Drugs:
Multiple Ascending Dose Safety, Tolerability and Pharmacokinetics of MK-7602 in Healthy Volunteers for Malaria

Not recruiting

1 1
Efficacy of Tranexamic Acid in Reducing Perioperative Blood Loss in Patients with Hip Fracture: A Randomized, Double-Blind Clinical Trial

Not recruiting

3 1 1 1
Investigated Drugs:
- Tranexamic Acid
Safety, tolerability, pharmacokinetics and food effect of BI 3000202 in healthy adult men: a randomised placebo‑controlled single‑dose study

Not recruiting

1 1
Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

Not recruiting

2 1 1
Investigated Diseases:
- Cutaneous lupus erythematosus
- Systemic lupus erythematosus
Investigated Drugs:
- Enpatoran
A study to evaluate how food affects the absorption of cytisinicline in healthy adult smokers

Not recruiting

1 1 1
Investigated Drugs:
- Cytisinicline
A study to compare how hydrochlorothiazide tablets work in healthy volunteers

Not recruiting

1 1 1 1
Investigated Drugs:
- Hydrochlorothiazide
Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

Not recruiting

3 1
Investigated Diseases:
- Systemic lupus erythematosus
Investigated Drugs:
- Litifilimab
Safety and Tolerability of REGN7999 in Healthy Adult Participants

Not recruiting

1 1 1
Investigated Diseases:
- Iron overload
Investigated Drugs:
- REGN7999
Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

Not recruiting

3 1 1
Investigated Drugs:
- Sodium Chloride
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies